April 2025

Resiliva

Resiliva Medicine 1

Introduction Cytosor 100 mg (Cytarabine) Injection is a potent antimetabolite chemotherapy agent designed for the treatment of acute leukemias and leukemic meningitis. Manufactured by Eskayef Pharmaceuticals Ltd. and supplied globally by Onco Solution, Cytosor 100 mg (Cytarabine) Injection inhibits DNA synthesis, effectively targeting rapidly dividing cancer cells. With its proven efficacy and manageable safety profile, Cytosor 100 mg (Cytarabine) Injection is a cornerstone […]

Resiliva Medicine 1 Read More »

Osimertinib

Osimertinib Medicine 1

Introduction Cytosor 100 mg (Cytarabine) Injection is a potent antimetabolite chemotherapy agent designed for the treatment of acute leukemias and leukemic meningitis. Manufactured by Eskayef Pharmaceuticals Ltd. and supplied globally by Onco Solution, Cytosor 100 mg (Cytarabine) Injection inhibits DNA synthesis, effectively targeting rapidly dividing cancer cells. With its proven efficacy and manageable safety profile, Cytosor 100 mg (Cytarabine) Injection is a cornerstone

Osimertinib Medicine 1 Read More »

Pembrolizumab

Pembrolizumab Medicine 1

Introduction Cytosor 100 mg (Cytarabine) Injection is a potent antimetabolite chemotherapy agent designed for the treatment of acute leukemias and leukemic meningitis. Manufactured by Eskayef Pharmaceuticals Ltd. and supplied globally by Onco Solution, Cytosor 100 mg (Cytarabine) Injection inhibits DNA synthesis, effectively targeting rapidly dividing cancer cells. With its proven efficacy and manageable safety profile, Cytosor 100 mg (Cytarabine) Injection is a cornerstone

Pembrolizumab Medicine 1 Read More »

Osimert 80 mg (Osimertinib): Transforming Cancer Care in India | Osimert 80 mg (ओसिमर्टिनिब): भारत में कैंसर के इलाज में कैसे बदलाव ला रहा है?

Cancer treatment has evolved significantly with targeted therapies like, a breakthrough drug for EGFR-mutant non-small cell lung cancer (NSCLC). This medication has transformed cancer care in India, offering improved survival rates and better quality of life for patients. कैंसर के इलाज में ओसिमर्ट 80 mg (ओसिमर्टिनिब) जैसी लक्षित चिकित्सा (Targeted Therapy) ने महत्वपूर्ण प्रगति की है। यह दवा ईजीएफआर

Osimert 80 mg (Osimertinib): Transforming Cancer Care in India | Osimert 80 mg (ओसिमर्टिनिब): भारत में कैंसर के इलाज में कैसे बदलाव ला रहा है? Read More »

Enasidenib

Enasidenib Medicine

Introduction Dasatab 20 mg (Dasatinib) Tablet is a highly effective tyrosine kinase inhibitor designed for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL). Manufactured by Eskayef Pharmaceuticals Ltd. and supplied globally by Onco Solution, Dasatab 20 mg (Dasatinib) Tablet targets BCR-ABL and SRC family kinases, offering a potent therapeutic option for patients resistant

Enasidenib Medicine Read More »